Abstract:1049 Objectives There is evidence that patients with diabetes mellitus have an increased risk of developing Alzheimer disease. It’s hypothesized that advanced glycation end-products (AGEs) accumulate in the organs and tissues affected by chronic diabetes, thus leading to Alzheimer’s disease. AGEs can further activate a specific type of receptor called RAGE (receptor for advanced glycation end products), which is a subtype of immunoglobulin receptors. The objective of this study was to radiosynthesize 18F-FPS-ZM1, a RAGE-specific PET tracer which can be used to further explore the link between diabetes and Alzheimer’s disease, and to evaluate its biological characteristics. Methods We designed a new probe 18F-FPS-ZM1 targeted RAGE screened from thousands of small molecules. The precursor and standard reference compounds of 18F -FPS-ZM1 were synthesized and identified. We tested different radiolabeled methods and proposed automated radiosynthesis processes in the production of 18F-FPS-ZM1. The biodistribution of 18F-FPS-ZM1was determined ex vivo in healthy mice after intravenous injection. In addition, its biological characteristics, acute toxicity, as well as microPET imaging and autoradiography on dementia and diabetic models were evaluated. Results 18F -FPS-ZM1 was radiosynthesized with high radiochemical purity (>99%) and activity (30mCi/mL). 18F-FPS-ZM1is electrically neutral. The lipophilicity of 18F-FPS-ZM1 is determined by lipid-water partition coefficient (lgP), and the lgP is 1.87, indicating 18F-FPS-ZM1 is lipophilic. Radiochemical purity of 18F-FPS-ZM1 remains stable at the level about 100% up to 6 hours in PBS vitro, while radiochemical purity of 18F-FPS-ZM1 is 55% in serum. Meanwhile, our blood kinetic studies had shown that the distribution and elimination of 18F-FPS-ZM1 were coincident with the results given by compartment modeling. 18F-FPS-ZM1 was quickly distributed from blood to other organs (t1/2α= 1.38 min), and had relatively favorable retention time in target organs (t1/2β= 6.19 hour). The statistical moment parameters of t1/2 in female and male mice were 5.51h and 4.02h respectively. Biodistribution of 18F-FPS-ZM1 displayed high brain permeability in the beginning. Later on, 18F-FPS-ZM1 was cleared rapidly from C57BL/6J mice brains and most other organs (except for liver, cecum and gonad), indicating low non-specific binding in brain and those organs vivo. The uptake of female mice was higher than male mice in brain and other organs. Micro PET imaging indicated that the uptake of 18F-FPS-ZM1 in brain was higher in dementia models (B6C3-Tg(APPswe,PSEN1dE9)85Dbo/MmJNju) than in type 2 diabetic models (BKS.Cg-Dock7m +/+ Leprdb/JNju) and type 1 diabetic models. The results of autoradiography is coincident with Micro PET imaging, especially in hippocampus and cortex. The acute toxicity studies of [11C]-TKF was negative. Conclusions Alzheimer’s disease is a neuroendocrine disorder of the brain which currently has no effective treatment, bringing heavy burden to family and the society. There is evedence that AD is related to diabetes, yet the relationship is not clearly understood. In this work, we tested different radiolabeled methods and proposed automated radiosynthesis processes in the production of 18F-FPS-ZM1, a candidate which might be used to further explore the link between diabetes and Alzheimer’s disease. We evaluate a wide range of biological characterics of 18F-FPS-ZM1. With low molecular weight, 18F-FPS-ZM1 was stable, electrically neutral, lipophilic and non-mass concentration-dependent. Micro PET imaging and autoradiography indicate 18F-FPS-ZM1is a promising RAGE-specific probe. As potential brain imaging tracer. 18F-FPS-ZM1 might be a promising biomarker for early detection of Alzheimer9s disease for patients with diabetes.

Reduced SV2A and GABA A receptor levels in the brains of type 2 diabetic rats revealed by [ 18 F]SDM-8 and [ 18 F]flumazenil PET

Reduced SV2A and GABAA receptor levels in the brains of type 2 diabetic rats revealed by [18F]SDM-8 and [18F]flumazenil PET

[The Investigation of Syn and NPY Expression in Brain Tissues of Diabetic Model Rat Induced by Streptozotocin].

Positron Emission Tomography Imaging Study of Mild Cognitive Impairment in Patients with 2 Type Diabetes Mellitus

Specific Changes of Somatostatin Mrna Expression in the Frontal Cortex and Hippocampus of Diabetic Rats

Analysis of Neuron–astrocyte Metabolic Cooperation in the Brain of Db/db Mice with Cognitive Decline Using 13C NMR Spectroscopy

A Novel Thiazolidinediones ATZD2 Rescues Memory Deficits in a Rat Model of Type 2 Diabetes Through Antioxidant and Anti-Inflammation

Cognitive decline in type 2 diabetic db/db mice may be associated with brain region-specific metabolic disorders.

Cognitive Deficits and Alzheimer-like Neuropathological Impairments During Adolescence in a Rat Model of Type 2 Diabetes Mellitus

Cerebral Perfusion Alterations in Type 2 Diabetes and Its Relation to Insulin Resistance and Cognitive Dysfunction

[A study of microPET for assessing regional cerebral glucose metabolism and the expression of dopamine receptor type 2 in a rat model of Parkinson's disease].

Targeting Insulin Signaling for the Treatment of Alzheimer's Disease.

Three-dimensional-arterial spin labeling perfusion correlation with diabetes-associated cognitive dysfunction and vascular endothelial growth factor in type 2 diabetes mellitus rat

The Research on the Relationship of RAGE, LRP-1, and Aβ Accumulation in the Hippocampus, Prefrontal Lobe, and Amygdala of STZ-Induced Diabetic Rats

Establishment of Animal Model of Type 2 Diabetes and 18F-FP-(+)-DTBZ PET Imaging Study

Exploratory Dual PET imaging of [18F] fluorodeoxyglucose and [11C]acetoacetate in type 2 diabetic nonhuman primates

RAGE-specific probe 18F -FPS-ZM1 may be a promising biomarker for early detection of Diabetes with Alzheimer's disease

The fractional amplitude of low-frequency fluctuations signals related to amyloid uptake in high-risk populations—A pilot fMRI study

Altered gene expression profiles in the hippocampus and prefrontal cortex of type 2 diabetic rats

Exacerbation of Poststroke Dementia by Type 2 Diabetes is Associated with Synergistic Increases of Β-Secretase Activation and Β-Amyloid Generation in Rat Brains

Decreased Striatal VMAT2 Expression in Rat Model of Hyperglycemia by F-18-FP-(+)-DTBZ-PET/CT